Point State Capital LP Gsk PLC Transaction History

Point State Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $2.32 Million - $2.64 Million	55,286 Added 100.0%	110,572 $4.91 Million
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $2.32 Million - $2.64 Million	55,286 New	55,286 $2.41 Million
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $4.43 Million - $5.25 Million	-110,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $3.83 Million - $4.46 Million	-98,500 Reduced 47.24%	110,000 $4.85 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $1.45 Million - $1.62 Million	37,500 Added 21.93%	208,500 $7.97 Million

Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $6.24 Million - $7.09 Million	171,000 New	171,000 $6.81 Million

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $77.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.